A Bioequivalence Trial of Lenvatinib Mesylate Capsules in Healthy Subjects Under Fasting and Postprandial Conditions

Ähnliche Einträge

• Bioequivalence and Pharmacokinetics of Ibuprofen Extended‐Release Capsules in Healthy Chinese Volunteers Under Fasting and Postprandial Conditions
  von: Mingqi Chen, et al.
  Veröffentlicht: (2025)
• Pharmacokinetic and Bioequivalence Evaluation of Ulipristal Acetate in Healthy Chinese Subjects in the Fasting and Postprandial Conditions
  von: Ling He, et al.
  Veröffentlicht: (2025)
• Pharmacokinetics, Bioequivalence, and Safety of Bromocriptine Mesylate Tablets in Healthy Chinese Subjects
  von: Huan Song, et al.
  Veröffentlicht: (2025)
• Bioequivalence Analysis of Clindamycin Hydrochloride Capsules in Healthy Chinese Subjects Under Fasted and Fed Conditions
  von: Zhi Wang, et al.
  Veröffentlicht: (2024)
• Pharmacokinetic and Bioequivalence Evaluation of Dihydroxyaluminum Aminoacetate, Heavy Magnesium Carbonate, and Aspirin Tablets in Healthy Chinese Subjects in the Fasting and Postprandial Conditions
  von: Fang Yao, et al.
  Veröffentlicht: (2024)